Total Funding
56
60
Total FundingSeries A raised
Growth Score
-3 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
136099
Abfero Pharmaceuticals is a clinical stage pharmaceutical company that specializes in healthcare and medical industry.
- Raymond J. Bergeron: Co-Founder & Chief Scientific Officer
Steven Burke: Co-Founder
About the Company
Abfero Pharmaceuticals is a clinical-stage pharmaceutical company that specializes in the healthcare and medical industry. The company focuses exclusively on iron as a therapeutic target, its mission is to develop novel therapies for the treatment of iron-overload conditions.
It was founded in 2016 and headquartered in Lexington, Massachusetts.
